Conciseness

Mostly efficient, dense domain reference material, but there is tightening to do: the ASCII decision trees ("Is predicate device available?...") duplicate the Pathway Selection Matrix and Pre-Sub decision table; the "Regulatory Tracker Features" bullet list restates the tool table's purpose; and time-sensitive figures ("User Fee ~$22K (2024)", "~$135K", "~$440K", "2024-11-01" in the sample output) sit outside any staleness-tolerant section and will drift. Fits anchor 3 rather than 4 because several sections could be trimmed or are padded relative to their value.

Actionability

Fully actionable throughout: fill-in-ready templates (Regulatory Strategy, Impact Assessment), a 9-section 510(k) checklist, a worked Substantial Equivalence comparison example with real values ("±2mm vs ±3mm predicate"), a GSPR checklist row example, and a real script with copy-paste usage ("python regulatory_tracker.py --report status") plus sample output. Specific examples cover the common cases, matching anchor 5.

Workflow Clarity

All five workflows use a numbered 1–8 sequence ending in an explicit **Validation** checkpoint (e.g., "Validation: Submission accepted; MDUFA date received; tracking system updated"), with checklists for complex processes and error-recovery guidance via the deficiency-prevention table ("Common FDA Deficiencies and Prevention") and escalation criteria. This matches anchor 5's explicit-checkpoint, checklist, and recovery-loop pattern; anchor 4 would require missing checkpoints, which are present in every workflow.

Progressive Disclosure

Good structure: four real, one-level-deep reference files clearly signaled both inline ("See: references/fda-submission-guide.md") and in a References table with content descriptions; no nested references. The gap is that scripts/regulatory_pathway_analyzer.py — the larger of the two scripts — exists in the bundle but is never referenced in SKILL.md, leaving it undiscoverable. Fits anchor 4 ('minor organization gaps') rather than 5.

Specificity

Lists six concrete, named actions — "Prepares FDA 510(k), De Novo, and PMA submission packages; drafts responses to FDA deficiency letters and Notified Body queries; develops CE marking technical documentation under EU MDR 2017/745; coordinates multi-market approval strategies... maintains regulatory intelligence" — with specific regulations and jurisdictions, in third-person voice. Coverage is comprehensive across the domain's core activities, matching the anchor-5 exemplar; no meaningful gaps justify a 4.

Completeness

Explicitly answers both questions: the "what" is given by six concrete capability statements, and the "when" by the full clause "Use when users need to plan or execute FDA submissions, navigate 510(k) or PMA approval processes, achieve CE marking..." with concrete trigger phrases. This mirrors the anchor-5 exemplar structure exactly; a 4 would require a weaker or less explicit 'when', which is not the case.

Trigger Term Quality

The "Use when" clause includes natural phrases users would say: "plan or execute FDA submissions", "navigate 510(k) or PMA approval processes", "achieve CE marking", "prepare pre-submission meeting materials", "write regulatory strategy documents", "respond to agency queries". A few common variations are missing (e.g., "FDA clearance", "medical device registration", "premarket approval", "clinical evaluation"), which fits anchor 4 rather than the comprehensive synonym coverage of anchor 5.

Distinctiveness Conflict Risk

A clear niche (medical-device regulatory affairs) with distinct triggers — 510(k), PMA, CE marking, EU MDR 2017/745, Notified Body, pre-submission — that adjacent skills (QMS/ISO 13485, risk management) would not claim. Overlap risk with neighboring compliance skills is minimal, fitting anchor 5.